It is a multiple and sequential drug release technology. The technology helps deliver multiple drugs in a controlled, effective, and accurate manner to their targets in the body. A proof-of-concept research is studied on Ketoprofen and currently in talks with drug companies to adapt the technology for their target drug. A PCT patent application has been filed. It passed the examination stage successfully and ready for national entries.
Loading of multiple different drugs
Sequential release with tunable hydrophobicities & permeabilitiesEasy & Safe Loading of Drugs
Drugs can be loaded without any degradationControllable & Triggered Release
Controlled & delayed drug release by pH, temperature responsive hydrogels, or changing hydrophobicity of the aerogel coreHigh Loading Capacity in Different Size & Forms
High pore volumes and low densitiesBiocompatible
Both PEG hydrogel & silica aerogel are non-toxic & biocompatible
• PhD., 1989, Texas A&M University, Chemical Engineering
• PhD., 2004, Illinois Technology Institute, Biomedical Engineering
The technology will be implemented on target drugs of interested drug firms with joint research or research support, and the IP will be licensed-out.
|Field||:||Biotechnology and Health|
|Patent Application Publication Number||:||WO2012095346|
|For more information||:||email@example.com|